Filing Flows

Filing Flows › 13F managers › CVS Health

CVS Health: 13F portfolio Q2 2026 and what copying it returned

CVS Health's 13F for the quarter ended 2026-06-30 (filed Aug 6, 2026): 21 common-share positions, $225M reported. Copying each 13F the day after it was filed returned +47.4% from Nov 14, 2022 to Nov 6, 2026, against +84.5% for SPY.

Reported 13F assets$225M
Positions (common)21
Quarter2026-06-30
Clone return+47.4%
SPY, same days+84.5%
Clone max drawdown-19.0%

Copying the 13F

2022-112023-072024-032024-112025-072026-032026-11cloneSPY

Each 13F bought at the close of the first trading day after it was filed and held, drifting, until the next one; value-weighted over the common-share positions with a price (99.1% of the portfolio on average); 16 filings since Nov 10, 2022. Price returns for the clone and SPY alike (no dividends, no costs). A 13F lists only US long positions at quarter end, reported up to 45 days later.

Largest holdings (2026-06-30)

CVS Health: largest 13F holdings, 2026-06-30CVS Health: largest 13F holdings, 2026-06-30IGSB · iShares 1-5Y INV Grade$46.6MIGIB · iShares 5-10Y INV Grade$23.4MIEI · iShares 3-7 Year Treasury BO$21.5MSHY · iShares 1-3 Year Treasury BO$21.2MUSHY · iShares Broad USD High Yie…$17.7MEMB · iShares JP Morgan USD Emergi$17.4MAGG · iShares Core U.S. Aggregate$14.8MVCSH · Vanguard S/T Corp Bond ETF$9.5MIGLB · iShares 10+ Year INV GR$8.8MLQD · Ishr IBX USD Invgd CB Etf-Ui$7.6MHYG · Ishr IBX USD Hiyld CB Etf-Ui$7.2MVGIT · Vanguard Intermediate-Term…$5.0MJAAA · Janus Henderson AAA CLO ETF$5.0MJPST · JPMorgan Ultra-Short Income$5.0MVCIT · Vanguard Int-Term Corporate$5.0M
CVS Health: positions grown and trimmed in the quarter (change in shares; new positions and exits are listed below)CVS Health: positions grown and trimmed in the quarter (change in shares; new positions and exits are listed below)IGIB+374%IGSB+202%TLT+150%IGLB+75%EMB+68%USHY+37%SHY+11%
TickerCompanyWeightValueChange in the quarter
IGSBiShares 1-5Y INV Grade20.7%$46.6M+202.3%
IGIBiShares 5-10Y INV Grade10.4%$23.4M+374.4%
IEIiShares 3-7 Year Treasury BO9.5%$21.5Munchanged
SHYiShares 1-3 Year Treasury BO9.4%$21.2M+10.7%
USHYiShares Broad USD High Yield7.9%$17.7M+37.3%
EMBiShares JP Morgan USD Emergi7.7%$17.4M+68.2%
AGGiShares Core U.S. Aggregate6.6%$14.8Munchanged
VCSHVanguard S/T Corp Bond ETF4.2%$9.5Munchanged
IGLBiShares 10+ Year INV GR3.9%$8.8M+75.0%
LQDIshr IBX USD Invgd CB Etf-Ui3.4%$7.6Mnew
HYGIshr IBX USD Hiyld CB Etf-Ui3.2%$7.2Mnew
VGITVanguard Intermediate-Term T2.2%$5.0Munchanged
JAAAJanus Henderson AAA CLO ETF2.2%$5.0Munchanged
JPSTJPMorgan Ultra-Short Income2.2%$5.0Munchanged
VCITVanguard Int-Term Corporate2.2%$5.0Munchanged
TLTiShares 20+ Year Treasury BD1.9%$4.3M+150.0%
IEFiShares 7-10 Year Treasury B1.5%$3.3Munchanged
COMDirexion Auspice BRD Cmdty0.2%$489Knew
RSPInvesco S&P 500 Equal Weight0.2%$426K-91.3%
PRUPrudential Financial0.1%$290Kunchanged

Biggest adds

Biggest cuts

Track record

Of 2 position changes scored in 2 separate decisions, 0.0% were on the right side of SPY over the next three months (Disclosures → Smart money).

Open in Disclosures → every quarter, the clone month by month, the smart-money record

Source: SEC Form 13F-HR, filer CIK 64803. Not investment advice.